Seres Therapeutics, Inc. (MCRB): Price and Financial Metrics
MCRB Price/Volume Stats
| Current price | $0.70 | 52-week high | $1.53 |
| Prev. close | $0.72 | 52-week low | $0.54 |
| Day low | $0.69 | Volume | 703,900 |
| Day high | $0.72 | Avg. volume | 1,289,705 |
| 50-day MA | $0.77 | Dividend yield | N/A |
| 200-day MA | $0.86 | Market Cap | 122.07M |
MCRB Stock Price Chart Interactive Chart >
Seres Therapeutics, Inc. (MCRB) Company Bio
Seres Therapeutics is a microbiome therapeutics platform company, focuses on the development of biological drugs designed to restore health by repairing the function of a dysbiotic microbiome. The company was founded in 2010 and is based in Cambridge, Massachusetts.
MCRB Price Returns
| 1-mo | -7.81% |
| 3-mo | N/A |
| 6-mo | -16.39% |
| 1-year | -8.74% |
| 3-year | -90.46% |
| 5-year | -77.85% |
| YTD | -15.76% |
| 2024 | -40.64% |
| 2023 | -75.00% |
| 2022 | -32.77% |
| 2021 | -66.00% |
| 2020 | 610.14% |
Continue Researching MCRB
Want to do more research on Seres Therapeutics Inc's stock and its price? Try the links below:Seres Therapeutics Inc (MCRB) Stock Price | Nasdaq
Seres Therapeutics Inc (MCRB) Stock Quote, History and News - Yahoo Finance
Seres Therapeutics Inc (MCRB) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...